BICO Group AB (publ) (FRA:49Z)

Market Cap	128.05M
Revenue (ttm)	161.01M
Net Income (ttm)	-61.87M
Shares Out	n/a
EPS (ttm)	-0.88
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,500
Average Volume	696
Open	1.796
Previous Close	1.786
Day's Range	1.771 - 1.796
52-Week Range	1.636 - 4.100
Beta	n/a
RSI	48.36
Earnings Date	Feb 18, 2026

About BICO Group AB

BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as provides services focused on accelerating drug discovery and development. The Life Science Solutions segment supplies lab instrumentation, consumables...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2016
• Employees: 710
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 49Z

Financial Performance

In 2024, BICO Group AB's revenue was 1.95 billion, a decrease of -3.19% compared to the previous year's 2.01 billion. Losses were -5.50 million, -99.53% less than in 2023.

Financial numbers in SEK